Personal information

Activities

Employment (1)

University of Pennsylvania: Philadelphia, PA, US

2014-05-01 to 2020-07-15
Employment
Source: Self-asserted source
Jun Gui

Works (13)

Depalmitoylation Rewires FLT3-ITD Signaling and Exacerbates Leukemia Progression.

Blood
2021-06-10 | Journal article
Source: Self-asserted source
Jun Gui

Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway.

Nature communications
2021-03-19 | Journal article
Source: Self-asserted source
Jun Gui

Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis.

Oncogene
2020-08-17 | Journal article
Source: Self-asserted source
Jun Gui

Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungs.

Nature cancer
2020-05-25 | Journal article
Source: Self-asserted source
Jun Gui

The PKR-Like Endoplasmic Reticulum Kinase Promotes the Dissemination of Myc-Induced Leukemic Cells.

Molecular cancer research : MCR
2019-07-01 | Journal article
Source: Self-asserted source
Jun Gui

An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles.

Cancer cell
2019-01-14 | Journal article
Source: Self-asserted source
Jun Gui

Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy.

International journal of radiation oncology, biology, physics
2018-03-12 | Journal article
Source: Self-asserted source
Jun Gui

Downregulation of the IFNAR1 chain of type 1 interferon receptor contributes to the maintenance of the haematopoietic stem cells.

Cancer biology & therapy
2017-07-05 | Journal article
Source: Self-asserted source
Jun Gui

Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.

Cancer cell
2017-02-13 | Journal article
Source: Self-asserted source
Jun Gui

Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation.

The Journal of investigative dermatology
2016-06-29 | Journal article
Source: Self-asserted source
Jun Gui

Type I interferons mediate pancreatic toxicities of PERK inhibition.

Proceedings of the National Academy of Sciences of the United States of America
2015-12-01 | Journal article
Source: Self-asserted source
Jun Gui

Remission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulation.

Journal of cellular and molecular medicine
2015-03-01 | Journal article
Source: Self-asserted source
Jun Gui

A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.

PloS one
2012-09-28 | Journal article
Source: Self-asserted source
Jun Gui

Peer review (3 reviews for 3 publications/grants)

Review activity for Cell death and disease. (1)
Review activity for iScience. (1)
Review activity for Nature communications (1)